Literature DB >> 27384657

Roles of the Rabies Virus Phosphoprotein Isoforms in Pathogenesis.

Kazuma Okada1, Naoto Ito2, Satoko Yamaoka1, Tatsunori Masatani1, Hideki Ebihara3, Hideo Goto4, Kento Nakagawa1, Hiromichi Mitake1, Kota Okadera1, Makoto Sugiyama5.   

Abstract

UNLABELLED: Rabies virus (RABV) P gene mRNA encodes five in-frame start codons, resulting in expression of full-length P protein (P1) and N-terminally truncated P proteins (tPs), designated P2, P3, P4, and P5. Despite the fact that some tPs are known as interferon (IFN) antagonists, the importance of tPs in the pathogenesis of RABV is still unclear. In this study, to examine whether tPs contribute to pathogenesis, we exploited a reverse genetics approach to generate CE(NiP)ΔP2-5, a mutant of pathogenic CE(NiP) in which the P gene was mutated by replacing all of the start codons (AUG) for tPs with AUA. We confirmed that while CE(NiP) expresses detectable levels of P2 and P3, CE(NiP)ΔP2-5 has an impaired ability to express these tPs. After intramuscular inoculation, CE(NiP)ΔP2-5 caused significantly lower morbidity and mortality rates in mice than did CE(NiP), indicating that tPs play a critical role in RABV neuroinvasiveness. Further examinations revealed that this less neuroinvasive phenotype of CE(NiP)ΔP2-5 correlates with its impaired ability to replicate in muscle cells, indicative of the importance of tPs in viral replication in muscle cells. We also demonstrated that CE(NiP)ΔP2-5 infection induced a higher level of Ifn-β gene expression in muscle cells than did CE(NiP) infection, consistent with the results of an IFN-β promoter reporter assay suggesting that all tPs function to antagonize IFN induction in muscle cells. Taken together, our findings strongly suggest that tPs promote viral replication in muscle cells through their IFN antagonist activities and thereby support infection of peripheral nerves. IMPORTANCE: Despite the fact that previous studies have demonstrated that P2 and P3 of RABV have IFN antagonist activities, the actual importance of tPs in pathogenesis has remained unclear. Here, we provide the first evidence that tPs contribute to the pathogenesis of RABV, especially its neuroinvasiveness. Our results also show the mechanism underlying the neuroinvasiveness driven by tPs, highlighting the importance of their IFN antagonist activities, which support viral replication in muscle cells.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27384657      PMCID: PMC5008078          DOI: 10.1128/JVI.00809-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Improved recovery of rabies virus from cloned cDNA using a vaccinia virus-free reverse genetics system.

Authors:  Naoto Ito; Mutsuyo Takayama-Ito; Kentaro Yamada; Junji Hosokawa; Makoto Sugiyama; Nobuyuki Minamoto
Journal:  Microbiol Immunol       Date:  2003       Impact factor: 1.955

2.  Lyssavirus P gene characterisation provides insights into the phylogeny of the genus and identifies structural similarities and diversity within the encoded phosphoprotein.

Authors:  S A Nadin-Davis; M Abdel-Malik; J Armstrong; A I Wandeler
Journal:  Virology       Date:  2002-07-05       Impact factor: 3.616

3.  Involvement of the rabies virus phosphoprotein gene in neuroinvasiveness.

Authors:  Satoko Yamaoka; Naoto Ito; Seii Ohka; Shohei Kaneda; Hiroko Nakamura; Takahiro Agari; Tatsunori Masatani; Keisuke Nakagawa; Kazuma Okada; Kota Okadera; Hiromichi Mitake; Teruo Fujii; Makoto Sugiyama
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

4.  Sensitivity of rabies virus to type I interferon is determined by the phosphoprotein gene.

Authors:  Kenta Shimizu; Naoto Ito; Makoto Sugiyama; Nobuyuki Minamoto
Journal:  Microbiol Immunol       Date:  2006       Impact factor: 1.955

5.  Role of interferon antagonist activity of rabies virus phosphoprotein in viral pathogenicity.

Authors:  Naoto Ito; Gregory W Moseley; Danielle Blondel; Kenta Shimizu; Caitlin L Rowe; Yuki Ito; Tatsunori Masatani; Keisuke Nakagawa; David A Jans; Makoto Sugiyama
Journal:  J Virol       Date:  2010-04-28       Impact factor: 5.103

6.  Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies.

Authors:  Danielle Blondel; Tarick Regad; Nicolas Poisson; Benjamen Pavie; Francis Harper; Pier Paolo Pandolfi; Hugues De Thé; Mounira K Chelbi-Alix
Journal:  Oncogene       Date:  2002-11-14       Impact factor: 9.867

7.  Genetic dissection of interferon-antagonistic functions of rabies virus phosphoprotein: inhibition of interferon regulatory factor 3 activation is important for pathogenicity.

Authors:  Martina Rieder; Krzysztof Brzózka; Christian K Pfaller; James H Cox; Lothar Stitz; Karl-Klaus Conzelmann
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

8.  The importance of being short: the role of rabies virus phosphoprotein isoforms assessed by differential IRES translation initiation.

Authors:  Adriane Marschalek; Lisa Drechsel; Karl-Klaus Conzelmann
Journal:  Eur J Cell Biol       Date:  2011-03-12       Impact factor: 4.492

9.  Rabies virus nucleoprotein functions to evade activation of the RIG-I-mediated antiviral response.

Authors:  Tatsunori Masatani; Naoto Ito; Kenta Shimizu; Yuki Ito; Keisuke Nakagawa; Yoshiharu Sawaki; Hiroyuki Koyama; Makoto Sugiyama
Journal:  J Virol       Date:  2010-02-03       Impact factor: 5.103

10.  Interaction of rabies virus P-protein with STAT proteins is critical to lethal rabies disease.

Authors:  Linda Wiltzer; Kazuma Okada; Satoko Yamaoka; Florence Larrous; Henna Veera Kuusisto; Makoto Sugiyama; Danielle Blondel; Hervé Bourhy; David Andrew Jans; Naoto Ito; Gregory William Moseley
Journal:  J Infect Dis       Date:  2013-12-23       Impact factor: 5.226

View more
  7 in total

Review 1.  Status of antiviral therapeutics against rabies virus and related emerging lyssaviruses.

Authors:  Venice Du Pont; Richard K Plemper; Matthias J Schnell
Journal:  Curr Opin Virol       Date:  2019-02-10       Impact factor: 7.090

2.  The Amino Acid at Position 95 in the Matrix Protein of Rabies Virus Is Involved in Antiviral Stress Granule Formation in Infected Cells.

Authors:  Isshu Kojima; Koji Onomoto; Wenjie Zuo; Makoto Ozawa; Kosuke Okuya; Kiyotada Naitou; Fumiki Izumi; Misuzu Okajima; Takuro Fujiwara; Naoto Ito; Mitsutoshi Yoneyama; Kentaro Yamada; Akira Nishizono; Makoto Sugiyama; Takashi Fujita; Tatsunori Masatani
Journal:  J Virol       Date:  2022-09-07       Impact factor: 6.549

3.  Molecular Basis of Functional Effects of Phosphorylation of the C-Terminal Domain of the Rabies Virus P Protein.

Authors:  Jingyu Zhan; Ericka Watts; Aaron M Brice; Riley D Metcalfe; Ashley M Rozario; Ashish Sethi; Fei Yan; Toby D M Bell; Michael D W Griffin; Gregory W Moseley; Paul R Gooley
Journal:  J Virol       Date:  2022-04-11       Impact factor: 6.549

4.  Optimization of Inhibitory Peptides Targeting Phosphoprotein of Rabies Virus.

Authors:  Yongzhong Lu; Linyue Cheng; Jie Liu
Journal:  Int J Pept Res Ther       Date:  2019-08-13       Impact factor: 1.931

5.  Increased Virulence of an Epidemic Strain of Vesicular Stomatitis Virus Is Associated With Interference of the Innate Response in Pigs.

Authors:  Lauro Velazquez-Salinas; Steven J Pauszek; Carolina Stenfeldt; Emily S O'Hearn; Juan M Pacheco; Manuel V Borca; Antonio Verdugo-Rodriguez; Jonathan Arzt; Luis L Rodriguez
Journal:  Front Microbiol       Date:  2018-08-15       Impact factor: 5.640

6.  Genetic and Phenotypic Characterization of a Rabies Virus Strain Isolated from a Dog in Tokyo, Japan in the 1940s.

Authors:  Tatsuki Takahashi; Maho Inukai; Michihito Sasaki; Madlin Potratz; Supasiri Jarusombuti; Yuji Fujii; Shoko Nishiyama; Stefan Finke; Kentaro Yamada; Hiroki Sakai; Hirofumi Sawa; Akira Nishizono; Makoto Sugiyama; Naoto Ito
Journal:  Viruses       Date:  2020-08-20       Impact factor: 5.048

7.  Defect of rabies virus phosphoprotein in its interferon-antagonist activity negatively affects viral replication in muscle cells.

Authors:  Satoko Yamaoka; Kazuma Okada; Naoto Ito; Kota Okadera; Hiromichi Mitake; Kento Nakagawa; Makoto Sugiyama
Journal:  J Vet Med Sci       Date:  2017-06-30       Impact factor: 1.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.